Two Sigma Advisers LP reduced its stake in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 46.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,600 shares of the semiconductor company's stock after selling 7,400 shares during the quarter. Two Sigma Advisers LP's holdings in Silicon Laboratories were worth $1,068,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. FMR LLC grew its holdings in shares of Silicon Laboratories by 0.5% during the fourth quarter. FMR LLC now owns 4,867,203 shares of the semiconductor company's stock worth $604,604,000 after buying an additional 23,833 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Silicon Laboratories by 1.9% during the 4th quarter. Vanguard Group Inc. now owns 3,959,580 shares of the semiconductor company's stock worth $491,859,000 after buying an additional 71,942 shares during the last quarter. Capital Research Global Investors lifted its stake in Silicon Laboratories by 23.3% in the fourth quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company's stock valued at $264,827,000 after buying an additional 403,010 shares during the last quarter. GW&K Investment Management LLC grew its position in Silicon Laboratories by 5.6% during the 4th quarter. GW&K Investment Management LLC now owns 682,045 shares of the semiconductor company's stock worth $84,723,000 after purchasing an additional 36,330 shares during the last quarter. Finally, Federated Hermes Inc. increased its holdings in shares of Silicon Laboratories by 4.1% in the fourth quarter. Federated Hermes Inc. now owns 638,464 shares of the semiconductor company's stock valued at $79,310,000 after purchasing an additional 25,178 shares during the period.
Insider Transactions at Silicon Laboratories
In other Silicon Laboratories news, Director Christy Wyatt sold 546 shares of the business's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $104.45, for a total value of $57,029.70. Following the transaction, the director now owns 8,492 shares in the company, valued at approximately $886,989.40. The trade was a 6.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert Matthew Johnson sold 5,879 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were sold at an average price of $131.20, for a total value of $771,324.80. Following the transaction, the chief executive officer now directly owns 73,688 shares of the company's stock, valued at approximately $9,667,865.60. This trade represents a 7.39% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,626 shares of company stock valued at $1,509,319. 1.60% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on SLAB shares. Stifel Nicolaus cut their target price on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. Needham & Company LLC restated a "buy" rating and issued a $150.00 target price on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Barclays decreased their price target on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 22nd. Wall Street Zen raised shares of Silicon Laboratories from a "sell" rating to a "hold" rating in a research note on Wednesday, May 14th. Finally, Susquehanna raised their price target on shares of Silicon Laboratories from $100.00 to $110.00 and gave the company a "neutral" rating in a report on Wednesday, May 14th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $126.50.
View Our Latest Report on Silicon Laboratories
Silicon Laboratories Trading Up 0.2%
NASDAQ SLAB traded up $0.21 on Wednesday, hitting $125.33. 333,248 shares of the company's stock were exchanged, compared to its average volume of 338,062. Silicon Laboratories Inc. has a 52 week low of $82.82 and a 52 week high of $160.00. The stock has a market cap of $4.08 billion, a price-to-earnings ratio of -21.10 and a beta of 1.36. The stock has a 50-day moving average of $109.06 and a 200-day moving average of $122.51.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The semiconductor company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.01. The firm had revenue of $177.71 million during the quarter, compared to the consensus estimate of $177.48 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business's revenue was up 67.0% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.92) earnings per share. As a group, analysts predict that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Read More

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report